BioCentury | May 10, 2019
Emerging Company Profile

HopeMed: Targeting PRLR for chronic diseases

...for endometriosis or alopecia. Xoma Corp., AbbVie Inc. and Oncolix Inc. have anti-PRLR antibodies or PRLR...
...Peking University, Beijing, China Xoma Corp. (NASDAQ:XOMA), Berkeley, Calif. Targets PRL - Prolactin PRLR - Prolactin receptor Hongjiang...
...Prolactin receptor Hongjiang Li, Staff Writer BAY 1158061 AbbVie Inc. Bayer AG Hope Medicine Inc. Oncolix Inc. Peking University Xoma Corp. 5-alpha reductase GnRH/LHRH receptor Prolactin (PRL) Prolactin receptor (PRLR) Rui-Ping...
BioCentury | Apr 19, 2019
Finance

Hope for China’s academic spinouts

...years." In its deal with Bayer, Hope gained a global license to BAY 1158061. The anti-prolactin receptor (PRLR)...
...Ltd. I-Mab Biopharma Innovative Cellular Therapeutics Co. Ltd. Peking University Pfizer Inc. Roche Suzhou Ribo Life Science Co. Ltd. Zai Lab Ltd. Zhejiang University Prolactin receptor (PRLR)...
BioCentury | Apr 11, 2019
Company News

Hope Medicine in-licenses Bayer’s BAY 1158061

...a $26 million series A round to support clinical development of the human antibody targeting PRLR...
...Hope's series A. Targets: PRL - Prolactin; PRLR - Prolactin receptor Hongjiang Li, Staff Writer BAY 1158061 Bayer AG Prolactin (PRL) Prolactin receptor (PRLR) Endometriosis Hair...
BioCentury | Apr 10, 2019
Financial News

Venture roundup: Inozyme, Cullgen, EdiGENE, Hope Medicine

...exclusive, worldwide rights from Bayer AG (Xetra:BAYN) to develop and commercialize a human antibody targeting PRLR...
...Targets: ENPP1 - ectonucleotide pyrophosphatase/phosphodiesterase 1; PRLR - Prolactin receptor BioCentury Staff INZ-701 Cullgen Inc. Inozyme Pharma Inc. Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) Prolactin receptor (PRLR) EdiGENE...
BioCentury | Jul 25, 2016
Clinical News

XOMA 213: Phase II started

...213 (formerly LFA102 ) Business: Endocrine/Metabolic Molecular target: Prolactin receptor (PRLR) Description: Human IgG1 kappa mAb against prolactin receptor (PRLR)...
BioCentury | Aug 21, 2014
Distillery Therapeutics

Indication: Cancer

...Target/marker/pathway Summary Licensing status Publication and contact information Cancer Liver cancer Prolactin (PRL); PRL receptor (PRLR...
...signaling could help prevent hepatocellular carcinoma (HCC). In human and mouse liver cell lines, enhanced PRL-PRLR...
BioCentury | Oct 9, 2006
Tools & Techniques

A new growth hormone

...short bowel syndrome by Serono S.A. (SWX: SEO; SRA, Geneva, Switzerland). "NNZ-3006 doesn't bind the prolactin receptor...
...very different from all the other known forms of growth hormone," Gluckman told BioCentury. The prolactin receptor...
Items per page:
1 - 7 of 7